A short cut review was carried out to establish whether biphasic defibrillatory shocks were superior to monophasic shocks in patients in ventricular fibrillation. Altogether 337 papers were found using the reported search, of which seven presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.
Three part question
In [an adult in ventricular fibrillation] is [external biphasic shock better than monophasic shock] at [achieving defibrillation]?
Search strategy Medline 1966-06/03 using the OVID interface. Biphasic.mp AND (defib$.mp OR shock$.mp OR exp electric countershock) LIMIT to human AND English.
Search outcome
Altogether 337 papers were found of which seven related to out of hospital studies relevant to the original question.
Comment(s)
The studies shown in table 1 represent two independent groups of patients. The first two studies are a prospective randomised controlled trial (PRCT) and subsequent subgroup analysis of data from it. The last five studies represent ongoing investigation by a group of researchers with some overlap of patient groups between each study because of differing selection criteria and differing dates of study.
The PRCT provides good evidence for the superiority of biphasic defibrillation over monophasic. Analysis of the data from this study gives an NNT of three for successful defibrillation with first shock, and an NNT of four for successful defibrillation within the first three shocks by biphasic compared with monophasic waveforms. These out of hospital studies follow on from extensive in hospital and animal studies showing the superiority of biphasic defibrillation.
All the studies reported used the Heartstream Forerunner defibrillator with non-escalating 150 J shocks. This device uses an impedance compensating biphasic truncated exponential waveform. Laboratory and hospital based studies show the superiority of biphasic waveforms to be broadly applicable and not confined to this specific example of a biphasic waveform. Work is ongoing to refine which parameters of the waveform influence effectiveness. Evidence should be appraised for the effectiveness of the specific waveform used when selecting a defibrillator. Local considerations will determine when biphasic devices replace monophasic defibrillators.
c CLINICAL BOTTOM LINE Biphasic defibrillation is currently the best treatment for adult VF and should be used when available.
White RD. Early out-of-hospital experience with an impedance-compensating low-energy biphasic waveform automatic external defibrillator. J Interv Card Electrophysiol 1997; 1:203-8 Best evidence topic reports (BETs) summarise the evidence pertaining to particular clinical questions. They are not systematic reviews, but rather contain the best (highest level) evidence that can be practically obtained by busy practising clinicians. The search strategies used to find the best evidence are reported in detail in order to allow clinicians to update searches whenever necessary. The BETs published below were first reported at the Critical Appraisal Journal Club at the Manchester Royal Infirmary 1 or placed on the BestBETs web site. Each BET has been constructed in the four stages that have been described elsewhere.
2 The BETs shown here together with those published previously and those currently under construction can be seen at http://www.bestbets.org. 
Search outcome
Altogether 33 papers were found of which one was relevant (table 2).
Comment(s)
Ascorbate (and citrate) treatment have been extensively investigated in rabbits but there are no good human data. A randomised controlled trial is mentioned as being underway in papers in 1980, but has not been reported.
c CLINICAL BOTTOM LINE There is no good evidence for the routine use of ascorbate in alkali burns in humans. A well designed randomised controlled trial should be performed. Leucovorin (calcium folinate) in "antifreeze" poisoning Report by Angaj Ghosh, Senior Clinical Fellow Checked by Russell Boyd, Consultant Abstract A short cut review was carried out to establish whether the addition of intravenous calcium folinate to standard (ethanol) therapy reduced the visual complications of antifreeze (methanol and ethyleny glycol). Altogether 12 papers were found using the reported search, of which one animal study presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of this best paper are tabulated. A clinical bottom line is stated.
Clinical scenario
A man attends the emergency department having deliberately taken 150 ml of "antifreeze". The can of antifreeze has conveniently been brought along and you find it consists of a mixture of methanol and ethylene glycol. The Poisons Centre is contacted. In addition to treatment with ethanol it is suggested that intravenous Leucovorin (calcium folinate) is given. You wonder if there is any evidence to support this recommendation. 
Three part question

Search outcome
Altogether 12 papers were found, none of which were relevant to humans. One paper published in two different journals described studies on monkeys and suggested that the results could be extrapolated to humans (table 3).
Comment(s)
In humans methanol toxicity is characterised by a metabolic acidosis and an ocular toxicity that occur coincident with an accumulation of formate in blood. After experimental studies on monkeys, Noker and Tephly hypothesised that folate compounds could decrease formate accumulation after methanol by stimulating formate oxidation or utilisation and suggested a possible use for folates in the treatment of certain cases of human methanol poisoning.
c CLINICAL BOTTOM LINE There is no direct evidence of the usefulness of folates in methanol poisoning in humans. Local policy should be followed. 
Search outcome
Altogether 44 papers were found, only two papers compared the effects of adrenaline and vasopressin (table 4) .
Comment(s)
The total number of patients studied remains small. The only RCT looking at hospital inpatients has shown no benefit in administering vasopressin during cardiac arrest. Abstract A short cut review was carried out to establish whether femoral central venous lines were as reliable as subclavian or jugular lines at assessing right atrial filling pressure. Altogether 141 papers were found using the reported search, of which seven presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.
Clinical scenario
You have been called to the resuscitation room to see a 67 year old woman who has walked out in front of a bus while shopping in town. She has an obvious closed fracture of her left arm and she is complaining of abdominal pain and central neck pain. You elicit from her husband that she has had two heart attacks in the past and the drugs in her handbag are bendrofluazide, frumil, and lisinopril. Her blood pressure is 90/52 and her pulse is 105. You are concerned that she may be hypovolaemic, but you are aware of the dangers of giving too 
Search outcome
Altogether 141 papers of which nine were found to be relevant. These papers are shown in table 5.
Comment(s)
There is extensive and consistent evidence that right atrial pressure can be reliably measured using both inferior vena cava and common iliac venous pressure measurements in supine patients. This has been proved in ventilated and spontaneously breathing adults and children. The readings of inferior vena caval measured pressures seem to be around 0.5 mm Hg lower than superior vena caval measured pressure on average and rarely more than 3 mm Hg different. This may not apply to patients with raised intra-abdominal pressure but applies to patients with high PEEP or raised mean airway pressures.
c CLINICAL BOTTOM LINE Inferior vena caval or common iliac venous pressure can be used reliably to measure right atrial pressure and may be regarded as equivalent to readings of superior vena caval pressure. Abstract A short cut review was carried out to establish which of the Oucher or CHEOPS pain assessments were best for assessing pain in children. Altogether 12 papers were found using the reported search, of which three presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.
Clinical scenario A 3 year old child comes into casualty and you need to assess their pain. Would it be better to use the Oucher scale, a self report measure, or CHEOPS, a behavioural pain measure, as at this age using either seems equally valid. Search outcome Altogether 12 papers were found. Three of these addressed the subject indirectly, while testing efficacy of analgesia, they are reviewed in table 6.
Three part question
Comment(s)
The underlying question is whether pain behaviour tools (such as CHEOPS) or self report tools (such as Oucher) are more useable and valid in the assessment of pain in children capable of assessment by both methods. None of the papers addressed the question directly. There seems to be some disagreement as to whether the CHEOPS score correlates to the Oucher score or not. Jacobson et al states that they are correlated, but this may be unreliable as CHEOPS was used in an older age range than was intended. Sutters et al state that CHEOPS is less reliable in older children, though they do not support this with any evidence. The Beyer study uses the two scales in the correct age range but the study is small and conducted postoperatively and general applicability is therefore moot. Further studies using a larger sample of patients in a wide range of clinical situations are needed.
c CLINICAL BOTTOM LINE There is no evidence to show whether Oucher or CHEOPS is better at assessing pain in children. Local policy should be followed.
